Genetic predisposition to pediatric myeloid malignancies

Area of Science:

• Genetics
• Pediatric Oncology
• Molecular Biology

Background:

• Over 250 genetic disorders are linked to pediatric cancer predisposition.
• Specific syndromes like Down syndrome and RASopathies increase risks for certain leukemias.
• Germline mutations in genes like RUNX1 and CEBPA are associated with familial myeloid malignancies.

Purpose of the Study:

• To highlight the association between genetic disorders and pediatric myeloid malignancies.
• To emphasize the importance of identifying germline variants in affected children.
• To advocate for genetic counseling, familial screening, and follow-up for high-risk individuals.

Main Methods:

• Review of existing literature on genetic disorders and pediatric cancers.
• Identification of key germline mutations associated with myeloid malignancies using massive parallel sequencing.
• Discussion of the need for efficient screening systems.

Main Results:

• A significant number of children with myeloid malignancies may have specific germline variants.
• Germline mutations in RUNX1, CEBPA, GATA2, SRP72, ETV6, and DDX41 are linked to familial myeloid cancers.
• Massive parallel sequencing has advanced the identification of these mutations.

Conclusions:

• Precise diagnosis and genetic counseling are essential for pediatric cancer predisposition.
• Familial screening and follow-up programs are recommended for at-risk patients.
• Development of efficient screening systems for germline and somatic mutations is needed for diagnosis and prognosis.